Should we overcome the resistance to bioelectrical impedance in heart failure?
Stephen J Hankinson1, Charles H Williams1, Van-Khue Ton1,2
1Department of Medicine, Division of Cardiovascular Medicine, University of Maryland School of Medicine , Baltimore, MD, USA.
Insights
Bioelectrical impedance methods offer a noninvasive way to monitor body composition changes in heart failure patients. Further research is needed, but lung impedance shows promise for guiding treatment and improving outcomes.
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Technology
Background:
- Heart failure (HF) is linked to neurohormonal activation, causing detrimental changes in body composition.
- These changes include fluid overload, loss of muscle mass, reduced body fat, and decreased bone density.
- Bioelectrical impedance (BI) is a technique that assesses body composition by measuring electrical current flow through body fluids.
Purpose of the Study:
- To review the current evidence on bioelectrical impedance monitoring strategies in heart failure.
- To evaluate the potential of various BI techniques in the diagnosis, prognosis, and treatment of HF.
- To identify areas for future research and clinical application of BI in HF management.
Main Methods:
- A comprehensive literature search was conducted on PubMed and Scopus databases up to June 2020.
- Included studies encompassed cross-sectional, retrospective, prospective observational studies, and randomized controlled trials.
- Reviewed BI monitoring strategies included intrathoracic impedance, lung impedance, bioelectrical impedance vector analysis, leg BI, and thoracic bioreactance.
Main Results:
- Multiple BI monitoring strategies have been investigated for their utility in heart failure.
- Lung impedance demonstrated potential utility in guiding HF treatment, particularly in ST-elevation myocardial infarction patients.
- Bioelectrical impedance vector analysis and other BI methods showed varied applications in HF assessment.
Conclusions:
- While promising, further studies are required to fully validate bioelectrical impedance techniques in heart failure.
- Lung impedance shows potential for improving outcomes in outpatient HF management.
- Bioelectrical impedance offers a noninvasive, quantitative tool for heart failure research, including population studies.
Introduction:
Heart failure is associated with increased neurohormonal activation that results in changes in body composition including volume overload and the loss of skeletal muscle, body fat, and bone density. Bioelectrical impedance measures body composition based on the conduction of electrical current through body fluids.
Areas Covered:
The PubMed and Scopus databases were reviewed up to the third week of June 2020. Cross-sectional studies, retrospective observational studies, prospective observational studies, and randomized controlled trials have examined numerous bioelectrical impedance monitoring strategies to guide the diagnosis, prognosis, and treatment of heart failure. These monitoring strategies include intrathoracic impedance, lung impedance, bioelectrical impedance vector analysis, leg bioelectrical impedance, and thoracic bioreactance.
Expert Commentary:
Based on the current evidence, more studies are needed to validate bioelectrical impedance in heart failure. Lung impedance appears to be useful for guiding heart failure treatment in patients with ST-elevation myocardial infarction and improving outcomes in outpatients with heart failure. Furthermore, bioelectrical impedance has potential as a noninvasive, quantitative heart failure variable for population-based research.
More Related Videos
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure II: Pathophysiology
Heart Failure VII: Nursing Interventions
Bode Plots Construction
Heart Failure I: Introduction


